Opiate Substitution Treatment

"Opiate Substitution Treatment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Medical treatment for opioid dependence using a substitute opiate such as METHADONE or BUPRENORPHINE.

Descriptor ID	D058850
MeSH Number(s)	E02.319.620
Concept/Terms	Opiate Substitution Treatment Opiate Substitution Treatment Opiate Substitution Treatments Substitution Treatment, Opiate Substitution Treatments, Opiate Treatment, Opiate Substitution Treatments, Opiate Substitution Opioid Substitution Treatment Opioid Substitution Treatments Substitution Treatment, Opioid Substitution Treatments, Opioid Treatment, Opioid Substitution Treatments, Opioid Substitution Opioid Substitution Therapy Opioid Substitution Therapies Substitution Therapies, Opioid Substitution Therapy, Opioid Therapies, Opioid Substitution Therapy, Opioid Substitution Opiate Replacement Therapy Opiate Replacement Therapies Replacement Therapies, Opiate Replacement Therapy, Opiate Therapies, Opiate Replacement Therapy, Opiate Replacement Opioid Replacement Therapy Opioid Replacement Therapies Replacement Therapies, Opioid Replacement Therapy, Opioid Therapies, Opioid Replacement Therapy, Opioid Replacement

Below are MeSH descriptors whose meaning is more general than "Opiate Substitution Treatment".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Opiate Substitution Treatment [E02.319.620]

Below are MeSH descriptors whose meaning is more specific than "Opiate Substitution Treatment".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Opiate Substitution Treatment" by people in this website by year, and whether "Opiate Substitution Treatment" was a major or minor topic of these publications.

Bar chart showing 154 publications over 17 distinct years, with a maximum of 21 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	1	0	1
2011	2	0	2
2012	6	1	7
2013	3	1	4
2014	5	1	6
2015	9	0	9
2016	6	2	8
2017	6	3	9
2018	6	2	8
2019	5	3	8
2020	3	5	8
2021	1	8	9
2022	0	17	17
2023	0	10	10
2024	14	7	21
2025	12	4	16
2026	10	1	11

Below are the most recent publications written about "Opiate Substitution Treatment" by people in Profiles.

Evans EA, Stopka TJ, Pivovarova E, Ryan D, Murphy SM, Jaffe K, Bernson D, Bovell-Ammon B, McCollister KE, Bianchet E, Hoskinson R, Friedmann PD. Jail-based opioid treatment implementation, outcomes, and costs: lessons learned from the Massachusetts Justice Community Opioid Innovation Network (MassJCOIN). Harm Reduct J. 2026 10 23; 23(1).

View in: PubMed
Ameral V, Falcón AK, Wolkowicz NR, Patterson JA, MacLean RR. Psychiatric Comorbidity in Research on Medications for Opioid Use Disorder: A Systematic Review. J Nerv Ment Dis. 2026 Sep-Oct 01; 214(5):97-116.

View in: PubMed
Martin R, Carpenter R, Hoadley A, Bailey A, Kang A, Rich J, Rohsenow D, Hurley L, Clarke J. Population-level benefits of correctional medications for opioid use disorder. J Subst Use Addict Treat. 2026 Dec; 191:210111.

View in: PubMed
Bailey A, Hughto JMW, Kelly PJA, Dunsiger SI, Martin RA. Patient preferences for medications to treat opioid use disorder in carceral settings: Implications for tailored implementation and service delivery. J Subst Use Addict Treat. 2026 Dec; 191:210099.

View in: PubMed
Bailey A, Kang AW, Glenn VP, Tavares T, Adams J, McNiff L, Hurley L, Martin RA. How mobile units are shaping opioid treatment experiences: Insights from patients of mobile and traditional opioid treatment programs. J Subst Use Addict Treat. 2026 Dec; 191:210100.

View in: PubMed
Monico LB, Bambury EA, Foreman JK, Avila M, Martin SA. Retention in Telehealth-Delivered Buprenorphine Treatment for Opioid Use Disorder: Multistate Retrospective Cohort Study. J Med Internet Res. 2026 08 14; 28:e100527.

View in: PubMed
Hsu HE, Lodi S, Yan S, Bovell-Ammon BJ, Christine PJ, Tilhou AS, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment. JAMA Netw Open. 2026 07 01; 9(7):e2623280.

View in: PubMed
Bailey A, Kang AW, Martin RA. Advancing Opioid Use Disorder Treatment: A Narrative Review of Evidence-Based Solutions to Systems-Level Barriers in the US. Subst Use Addctn J. 2026 Oct; 47(4):1244-1256.

View in: PubMed
Stopka TJ, Rottapel RE, Ruggiro M, Santelices C, Friedmann PD, Pivovarova E, Evans EA. "So what's gonna happen when I get out of here?" Qualitative barriers and facilitators to MOUD continuity post-release from jail. Drug Alcohol Depend. 2026 Aug 01; 285:113227.

View in: PubMed
Votaw VR, Rosen RL, Peckham AD, London Z, Philpotts LL, Weiss RD, McHugh RK, Streck JM. Investigating the Effects of Buprenorphine Treatment on Depression Symptoms Among Adults with Opioid Use Disorder: A Scoping Review. J Dual Diagn. 2026 Apr; 22(2):158-190.

View in: PubMed

People

Explore

Similar Concepts

Top Journals